24-HOUR MH HOTLINE

800-644-9737

FOR EMERGENCIES ONLY

 

MHAUS Blog

President's Report 2015

by Dr. Henry Rosenberg MD, CPE

Tuesday, January 26, 2016 /

Tagged: Update on MH and MHAUS ·

2015 was another, busy, productive year for MHAUS. Dianne Daugherty, executive director, and her staff deserve special compliments for ensuring that MHAUS runs smoothly and meets the goals and objectives set forth by the Board of Directors.  New programs are introduced on a regular basis while the basic work of …

0 Comments · 1684 words · est. read time: 8 minutes · Read and Comment »

The New CHCT Equipment

by Guest Contributor

Monday, January 25, 2016 /

Tagged: General ·

Natalia Kraeva, PhD, MH investigation unit, Toronto, Canada The MHIU in Toronto, Canada has got a replacement for the CHCT apparatus, which had been used for the MH diagnosis for more than 35 years. The new MH measuring system, custom built for us by Biegler Medizinelektronik, Austria, fully complies with …

0 Comments · 170 words · est. read time: 1 minute · Read and Comment »

Eagle Pharmaceuticals Reports Successful Outcomes from Safety and Efficacy Study of RYANODEX for Exertional Heat Stroke

by MHAUS Staff

Thursday, January 21, 2016 /

Tagged: Press Release ·

Use of RYANODEX with Current Standard of Care (SOC) Showed Substantial Evidence of Increased Effectiveness in Treating EHS than SOC Alone Favorable Safety Data Shows No Significant Drug-Related Adverse Events in Patients Treated with RYANODEX Release Date: Thursday, December 17, 2015 6:50 am EST Dateline: WOODCLIFF LAKE, N.J. Public Company …

0 Comments · 2188 words · est. read time: 11 minutes · Read and Comment »

Merck's BRIDIONĀ® (sugammadex) Receives FDA Approval

by Guest Contributor

Friday, December 18, 2015 /

Tagged: Press Release ·

Merck’s BRIDION® (sugammadex) Receives FDA Approval for the Reversal of Neuromuscular Blockade Induced by Rocuronium and Vecuronium in Adults Undergoing Surgery KENILWORTH, N.J., Dec.17, 2015 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved …

0 Comments · 1619 words · est. read time: 8 minutes · Read and Comment »

New Laboratory to Offer Genetic Testing for MH Susceptibility and Related Disorders

by Dr. Geogirene Vladutiu, PhD

Tuesday, December 8, 2015 /

Tagged: General ·

Genetic testing for susceptibility to Malignant Hyperthermia is already offered by a number of commercial laboratories (see the MHAUS web site for details). A new laboratory, the Robert Guthrie Biochemical and Molecular Genetics Laboratory at Buffalo General Medical Center, Buffalo, New York is now offering genetic testing for MH and …

0 Comments · 535 words · est. read time: 3 minutes · Read and Comment »

New drug holds potential to reduce the use of a potent MH trigger drug

by Dr. Henry Rosenberg MD, CPE

Monday, November 16, 2015 /

Tagged: General ·

Succinylcholine (Anectine) is an MH trigger. Generally injected intravenously, the drug is usually used to produce deep muscle relaxation in order to facilitate such procedures as intubation of the trachea. The onset of relaxation is very rapid and the duration is generally less than 10 minutes. Succinylcholine, introduced in the …

0 Comments · 382 words · est. read time: 2 minutes · Read and Comment »

Henry Rosenberg, M.D., Named 2014 DSA Recipient

by MHAUS Staff

Monday, September 21, 2015 /

Tagged: General ·

Please read this wonderful article about Dr. Rosenberg, the President of MHAUS. Dr. Rosenberg is receiving an award this year at the American Society of Anethesiologists Annual Meeting. Join MHAUS in honoring Dr. Henry Rosenberg as he receives the ASA's Distinguished Service Award on October 24, 2015 in San Diego, …

2 Comments · 63 words · est. read time: 1 minute · Read and Comment »

My Graduate Student Experience with the Nurse Anesthesia Program at UP

by Guest Contributor

Wednesday, September 9, 2015 /

Tagged: General ·

My name is Brooke DiIanni and I am a graduate student in the nurse anesthesia program at the University Pittsburgh.  As part of our didactic curriculum we are afforded the opportunity to work side by side with a researcher and become personally involved with a research entity. Malignant Hyperthermia (MH) …

1 Comment · 537 words · est. read time: 3 minutes · Read and Comment »

A Summary of a SRNA's Summer at the NAMHR of MHAUS

by Guest Contributor

Wednesday, September 9, 2015 /

Tagged: General ·

As an undergraduate, I participated as a research assistant for a study on dementia. It was mostly data entry and busy work. When we were told we had to volunteer for a research project as part of our research practicum, I thought it would be more data entry. A classmate …

0 Comments · 581 words · est. read time: 3 minutes · Read and Comment »

Report on the 34th Annual European MH Group meeting, June 10-12, 2015

by Dr. Henry Rosenberg MD, CPE

Monday, June 29, 2015 /

Tagged: General ·

The annual meeting of the European MH group took place in the charming city of Lille, France. About 80 physicians, scientists, students and clinicians who are studying the problem of malignant hyperthermia attended, giving 41 presentations. Attendees came from many countries inside and outside Europe including the Soviet Union, South …

1 Comment · 2238 words · est. read time: 11 minutes · Read and Comment »